article thumbnail

Advancing research on human immune systems in India to develop better vaccines

Express Pharma

The vaccine efforts of the COVID-19 pandemic highlighted our knowledge about gaps in the immune system. Reductionist systems, such as genetically identical inbred mice, have long been the choice for immunology research, which focuses on studying the cells, tissues, and organs that make up the immune system.

Immunity 102
article thumbnail

Opinion: How to separate sound wellness solutions from seductive snake oil

STAT

Challenged public health communication fueled skepticism in science and medicine, compelling consumers to seek influencer-led health solutions to boost immunity, defy disease, and perhaps contest aging altogether.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Aptar and Healint announce collaboration on CNS and immune system conditions management

Pharmafile

AI healthcare company Healint and Software as a Medical Device (SaMD) expert Aptar Digital Health have announced a collaboration aiming to improve central nervous system (CNS) and immune system conditions management. read more

article thumbnail

After a Vaccine – What? The Shift from Research and Discovery to Communications

Eye on FDA

It is those folks in the middle who are the most important to communicate with. With respect to the latter, the article points out that to achieve the societal aim of ending the pandemic, then uptake will have to be strong to achieve the goal of herd immunity, even when combined with the huge numbers of people who have already been infected.

article thumbnail

IOnctura Awarded UK’s MHRA Innovation Passport For Entry ILAP

LifeProNow

Roginolisib is a first-in-class, non-ATP-competitive, allosteric modulator of PI3Kd which prevents tumor proliferation and breaks immune tolerance in patients with solid and hematological tumors. ” [link] The post IOnctura Awarded UK’s MHRA Innovation Passport For Entry ILAP appeared first on LifeProNow.

Immunity 130
article thumbnail

As the Prospect of a Vaccine Approaches, Business and Communications Challenges Are Just Around the Corner

Eye on FDA

Vaccination for COVID-19 not only requires business planning, but communications planning in support of the decisions. A post-vaccine environment is going to demand business plans and external and internal communications plans that support and consider multiple scenarios and contingencies.

article thumbnail

High levels of exposure to COVID virus may reduce protection from vaccination, prior infection: Study

Express Pharma

The study was performed to understand whether the immunity gained after vaccination or a prior infection was less effective or “leaky” in situations where people are exposed to high levels of the virus.